Brazil vs China: Cause of death, by non-communicable diseases, ages 0-4, female
Brazil
31.9%
in 2021
China
32.1%
in 2021
Brazil rank
88th
China rank
85th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Brazil
- China
How they compare
China currently reports 32.1% against 31.9% in Brazil, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 88th and China ranks 85th of 185 countries.
Across the 3 decades both report, Brazil averaged higher in 2 and China in 1.
Head to head by decade
| Decade | Brazil | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.3% | 18.2% | 3.1% | Brazil |
| 2010s | 31.4% | 30.0% | 1.4% | Brazil |
| 2020s | 31.9% | 32.0% | 0.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Brazil or China?
- China, at 32.1% against 31.9% in Brazil as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Brazil and China?
- 0.2%, with China ahead.
- How many years of comparable data are there for Brazil and China?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and China rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Brazil ranks 88th and China ranks 85th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.